Insights into the Use of Peripherally Acting µ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice.
Curr Treat Options Oncol
; 22(3): 26, 2021 02 26.
Article
in En
| MEDLINE
| ID: mdl-33635493
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, Opioid, mu
/
Cancer Pain
/
Medical Oncology
/
Narcotic Antagonists
Type of study:
Etiology_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Curr Treat Options Oncol
Journal subject:
NEOPLASIAS
Year:
2021
Type:
Article
Affiliation country:
Spain